• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

堪萨斯分枝杆菌对乙胺丁醇及其与利福霉素、环丙沙星和异烟肼联合用药的敏感性。

Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.

作者信息

Hjelm U, Kaustová J, Kubín M, Hoffner S E

机构信息

Department of Bacteriology, National Bacteriological Laboratory, Stockholm, Sweden.

出版信息

Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):51-4. doi: 10.1007/BF01971272.

DOI:10.1007/BF01971272
PMID:1563386
Abstract

The susceptibility of Mycobacterium kansasii to antibacterial agents alone and in combination was studied. Widespread resistance to ethambutol, ciprofloxacin and isoniazid was found when these drugs were tested separately. However, pronounced antibacterial effects were seen when ethambutol was tested in combination with ciprofloxacin, rifampicin or rifabutin, which corresponded to significantly decreased resistance to these drugs in combination.

摘要

研究了堪萨斯分枝杆菌对单独及联合抗菌药物的敏感性。当分别测试乙胺丁醇、环丙沙星和异烟肼时,发现对这些药物普遍存在耐药性。然而,当乙胺丁醇与环丙沙星、利福平或利福布汀联合测试时,观察到显著的抗菌效果,这与联合使用这些药物时耐药性显著降低相对应。

相似文献

1
Susceptibility of Mycobacterium kansasii to ethambutol and its combination with rifamycins, ciprofloxacin and isoniazid.堪萨斯分枝杆菌对乙胺丁醇及其与利福霉素、环丙沙星和异烟肼联合用药的敏感性。
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):51-4. doi: 10.1007/BF01971272.
2
Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.堪萨斯分枝杆菌对异烟肼、链霉素和乙胺丁醇敏感性的联合用药与单药研究
Am J Clin Pathol. 1978 Nov;70(5):816-20. doi: 10.1093/ajcp/70.5.816.
3
[Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].[抗生素组合对海分枝杆菌的巨噬细胞内活性]
Pathol Biol (Paris). 1991 May;39(5):436-41.
4
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.马尔默分枝杆菌对抗菌药物及药物组合的敏感性。
Antimicrob Agents Chemother. 1993 Jun;37(6):1285-8. doi: 10.1128/AAC.37.6.1285.
5
[Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].基于体外药敏试验评价异烟肼和乙胺丁醇治疗非结核分枝杆菌病的临床疗效
Kekkaku. 1989 Aug;64(8):511-8.
6
Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.采用 slomyco 测试系统对缓慢生长非结核分枝杆菌进行药物敏感性测试。
PLoS One. 2018 Sep 17;13(9):e0203108. doi: 10.1371/journal.pone.0203108. eCollection 2018.
7
Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.机会性分枝杆菌对利福平和乙胺丁醇的敏感性。
Tubercle. 1981 Jun;62(2):117-21. doi: 10.1016/0041-3879(81)90019-2.
8
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
9
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.堪萨斯分枝杆菌:临床分离株的抗生素敏感性及聚合酶链反应-限制性分析
J Med Microbiol. 2005 Oct;54(Pt 10):975-979. doi: 10.1099/jmm.0.45965-0.
10
Synergistic activity of rifampicin and ethambutol against slow-growing nontuberculous mycobacteria is currently of questionable clinical significance.利福平与乙胺丁醇联合治疗缓慢生长非结核分枝杆菌的活性目前具有临床意义。
Int J Antimicrob Agents. 2013 Jul;42(1):80-2. doi: 10.1016/j.ijantimicag.2013.03.010. Epub 2013 May 9.

引用本文的文献

1
Drug susceptibility profiling of pulmonary and its correlation with treatment outcome.肺部药物敏感性分析及其与治疗结果的相关性。
Ann Thorac Med. 2021 Oct-Dec;16(4):323-328. doi: 10.4103/atm.atm_45_21. Epub 2021 Oct 26.
2
Therapy for Infection: Beyond 2018.感染治疗:2018年之后
Front Microbiol. 2018 Sep 24;9:2271. doi: 10.3389/fmicb.2018.02271. eCollection 2018.
3
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.堪萨斯分枝杆菌的药物敏感性分析及耐药基因的遗传决定因素。

本文引用的文献

1
Basis for lack of drug susceptibility of atypical mycobacteria.非结核分枝杆菌耐药的基础。
Rev Infect Dis. 1981 Sep-Oct;3(5):878-84. doi: 10.1093/clinids/3.5.878.
2
Mycobacterium kansasii infection in an endemic area of Czechoslovakia.捷克斯洛伐克某流行地区的堪萨斯分枝杆菌感染
Tubercle. 1980 Dec;61(4):207-12. doi: 10.1016/0041-3879(80)90040-9.
3
Multiple drug resistance in Mycobacterium avium: is the wall architecture responsible for exclusion of antimicrobial agents?鸟分枝杆菌中的多重耐药性:细胞壁结构是抗菌药物排除的原因吗?
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.01788-17. Print 2018 Apr.
4
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.马尔默分枝杆菌对抗菌药物及药物组合的敏感性。
Antimicrob Agents Chemother. 1993 Jun;37(6):1285-8. doi: 10.1128/AAC.37.6.1285.
5
Clinical pharmacokinetics of rifabutin.利福布汀的临床药代动力学。
Clin Pharmacokinet. 1995 Feb;28(2):115-25. doi: 10.2165/00003088-199528020-00003.
6
Pulmonary infections caused by less frequently encountered slow-growing environmental mycobacteria.由较少见的生长缓慢的环境分枝杆菌引起的肺部感染。
Eur J Clin Microbiol Infect Dis. 1994 Nov;13(11):937-41. doi: 10.1007/BF02111495.
7
Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.氟喹诺酮类与其他抗菌药物类别的协同作用和拮抗作用。
Drugs. 1993;45 Suppl 3:54-8. doi: 10.2165/00003495-199300453-00011.
8
Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.利福布汀。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1994 Jun;47(6):983-1009. doi: 10.2165/00003495-199447060-00008.
Antimicrob Agents Chemother. 1981 Nov;20(5):666-77. doi: 10.1128/AAC.20.5.666.
4
Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods.采用放射测量法和传统方法测定液体培养基中鸟分枝杆菌复合群的安莎霉素最低抑菌浓度。
Antimicrob Agents Chemother. 1985 Oct;28(4):570-5. doi: 10.1128/AAC.28.4.570.
5
Determination of in vitro susceptibility of mycobacteria to ansamycin.分枝杆菌对安莎霉素的体外药敏测定。
Am Rev Respir Dis. 1985 Sep;132(3):710-1. doi: 10.1164/arrd.1985.132.3.710.
6
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.在液体培养基中通过放射性测定法确定抗分枝杆菌药物组合对鸟分枝杆菌复合群的协同作用。
Eur J Clin Microbiol. 1987 Oct;6(5):530-5. doi: 10.1007/BF02014241.
7
In-vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex.乙胺丁醇与氟喹诺酮类药物对鸟分枝杆菌复合群的体外协同活性。
J Antimicrob Chemother. 1989 Sep;24(3):317-24. doi: 10.1093/jac/24.3.317.
8
Ethambutol: a key for Mycobacterium avium complex chemotherapy?乙胺丁醇:鸟分枝杆菌复合群化疗的关键?
Am Rev Respir Dis. 1989 Jul;140(1):264. doi: 10.1164/ajrccm/140.1.264.
9
Studies on the mechanisms of the synergistic effects of ethambutol and other antibacterial drugs on Mycobacterium avium complex.乙胺丁醇与其他抗菌药物对鸟分枝杆菌复合群协同作用机制的研究。
Acta Leprol. 1989;7 Suppl 1:195-9.
10
Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media.在选择性培养基中对结核分枝杆菌生长进行可自动化的放射性检测。
Am Rev Respir Dis. 1977 Jun;115(6):1066-9. doi: 10.1164/arrd.1977.115.6.1066.